Comparison of sensitivity and variability of sGaw and FEV1 for measuring bronchodilation in healthy and asthmatic subjects Source: Eur Respir J 2004; 24: Suppl. 48, 338s Year: 2004
Effects of inhaled histamine and methacholine on the lung function parameters obtained by spirometry and forced oscillations in asthmatic children Source: Annual Congress 2010 - Lung function from infancy to adulthood Year: 2010
sGaw as an alternative for FEV1 in the measurement of airway responsiveness to methacholine in patients experiencing chronic cough Source: Annual Congress 2011 - Lung function today and tomorrow I Year: 2011
The influence of FVC manoeuvres on consecutive FEV1 values during methacholine challenge Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004
Tachyphylaxis to methacholine changes the dose-response curve in healthy non-asthmatic subjects Source: Eur Respir J 2004; 24: Suppl. 48, 442s Year: 2004
Maximally attained level of FEV1 and FEV1 decline determine airway hyperresponsiveness in adults Source: Eur Respir J 2003; 22: Suppl. 45, 17s Year: 2003
FEV1 bronchodilatation response in a population sample and healthy adults Source: Eur Respir J 2006; 28: Suppl. 50, 202s Year: 2006
Post-exercise changes in FEV1 values and in adenosine concentrations in exhaled-breath condensate in healthy subjects and patients with exercise-induced asthma Source: Eur Respir J 2002; 20: Suppl. 38, 290s Year: 2002
Should bronchodilator response be assessed in all asthmatic children with normal baseline spirometry? Source: International Congress 2018 – New ideas about respiratory and sleep physiology in children Year: 2018
Comparison of FEV1 and PEF values in cough variant asthma during methacholine challenge test Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010
PD40 sGaw with deep inhalation as alternative for PD20 FEV1 Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020
FEV1 response to albuterol is not affected by inhaled human insulin (Exubera®) use in subjects with mild-to-moderate asthma Source: Eur Respir J 2006; 28: Suppl. 50, 840s Year: 2006
Comparison of bronchodilatator response of FEV1 and airway resistance Source: Annual Congress 2003 - Assessing airway function: practicalities and clinical applications Year: 2003
Baseline FEV1 and sputum neutrophils and macrophages predict the decrease in FEV1 after inhaled corticosteroid withdrawal in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 306s Year: 2004
Respiratory impedance in healthy subjects: baseline values and bronchodilator response Source: Eur Respir J 2013; 42: 1513-1523 Year: 2013
FEV1 and respiratory resistance response to methacholine in children calculated from between-measurement variability Source: Eur Respir J 2005; 26: Suppl. 49, 43s Year: 2005
Airway responsiveness to methacholine and deep inhalations in obese subjects Source: Annual Congress 2008 - Lung function in respiratory disease Year: 2008
IsovolumeFEF25-75% 6 and FEV1 for identifying bronchodilator response Source: Eur Respir J 2006; 28: Suppl. 50, 156s Year: 2006
Relationship between bronchodilator response measured by FEV0.5 and methacholine provocation test in children from 3 to 15 years old Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease Year: 2009
Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV1 and FEV1 in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005